Ongoing and Planned Clinical Trials
Ongoing
RESMAIN – Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)
The pivotal RESMAIN study is a multi-national, multi-center, double-blind, randomized and placebo controlled study to evaluate resminostat for maintenance treatment of patients with advanced stage (Stage IIB‑IVB) Mycosis Fungoides (MF) or Sézary Syndrome (SS) that have achieved disease control with systemic therapy.
| Recruitment status | Open-label arm active |
| Study phase | Phase II, Pivotal |
| Enrollment | 201 |
| Primary objective |
|
|